Richemont Forecast, price target & analysts
Richemont Target price 2025 - Analyst rating & recommendation
Richemont Classifications & Recommendation:
Richemont Price Target
| Target Price | CHF174.51 |
| Price | CHF154.30 |
| Potential | 13.10% |
| Number of Estimates | 27 |
| 27 Analysts have issued a price target Richemont 2026 . The average Richemont target price is CHF174.51. This is 13.10% higher than the current stock price. The highest price target is CHF208.15 34.90% , the lowest is CHF141.48 8.31% . | |
| A rating was issued by 30 analysts: 17 Analysts recommend Richemont to buy, 13 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Richemont stock has an average upside potential 2026 of 13.10% . Most analysts recommend the Richemont stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 19.80 | 20.39 |
| 0.10% | 2.94% | |
| EBITDA Margin | 30.52% | 27.88% |
| 5.56% | 8.66% | |
| Net Margin | 11.64% | 9.81% |
| 7,788.05% | 15.76% |
27 Analysts have issued a sales forecast Richemont 2025 . The average Richemont sales estimate is CHF20.4b . This is 4.05% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF21.6b 10.03% , the lowest is CHF19.6b 0.13% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | CHF19.8b | 0.10% |
|---|---|---|
| 2025 | CHF20.4b | 2.94% |
| 2026 | CHF21.8b | 6.74% |
| 2027 | CHF23.3b | 7.06% |
| 2028 | CHF25.2b | 8.11% |
| 2029 | CHF27.3b | 8.40% |
24 Analysts have issued an Richemont EBITDA forecast 2025. The average Richemont EBITDA estimate is CHF5.7b . This is 0.54% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF6.1b 7.17% , the lowest is CHF4.7b 17.13% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | CHF6.0b | 5.65% |
|---|---|---|
| 2025 | CHF5.7b | 5.99% |
| 2026 | CHF6.3b | 11.47% |
| 2027 | CHF7.0b | 10.85% |
| 2028 | CHF7.3b | 3.42% |
EBITDA Margin
| 2024 | 30.52% | 5.56% |
|---|---|---|
| 2025 | 27.88% | 8.66% |
| 2026 | 29.11% | 4.41% |
| 2027 | 30.14% | 3.54% |
| 2028 | 28.84% | 4.31% |
11 Richemont Analysts have issued a net profit forecast 2025. The average Richemont net profit estimate is CHF2.0b . This is 59.67% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF2.3b 80.54% , the lowest is CHF949m 24.22% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | CHF2.3b | 7,780.00% |
|---|---|---|
| 2025 | CHF2.0b | 13.28% |
| 2026 | CHF3.9b | 94.98% |
| 2027 | CHF4.4b | 13.53% |
| 2028 | CHF4.7b | 5.36% |
Net Margin
| 2024 | 11.64% | 7,788.05% |
|---|---|---|
| 2025 | 9.81% | 15.76% |
| 2026 | 17.92% | 82.67% |
| 2027 | 19.00% | 6.03% |
| 2028 | 18.52% | 2.53% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Mar '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 3.94 | 3.42 |
| 7,780.00% | 13.20% | |
| P/E | 45.16 | |
| EV/Sales | 4.35 |
11 Analysts have issued a Richemont forecast for earnings per share. The average Richemont EPS is CHF3.42 . This is 59.81% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF3.86 80.37% , the lowest is CHF1.62 24.30% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | CHF3.94 | 7,780.00% |
|---|---|---|
| 2025 | CHF3.42 | 13.20% |
| 2026 | CHF6.66 | 94.74% |
| 2027 | CHF7.56 | 13.51% |
| 2028 | CHF7.97 | 5.42% |
P/E ratio
| Current | 72.13 | 44.23% |
|---|---|---|
| 2025 | 45.16 | 37.39% |
| 2026 | 23.16 | 48.72% |
| 2027 | 20.40 | 11.92% |
| 2028 | 19.36 | 5.10% |
Based on analysts' sales estimates for 2025, the Richemont stock is valued at an EV/Sales of 4.35 and an P/S ratio of 4.43 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.53 | 1,577.78% |
|---|---|---|
| 2025 | 4.35 | 3.96% |
| 2026 | 4.08 | 6.31% |
| 2027 | 3.81 | 6.59% |
| 2028 | 3.52 | 7.50% |
| 2029 | 3.25 | 7.75% |
P/S ratio
| Current | 4.61 | 1,188.65% |
|---|---|---|
| 2025 | 4.43 | 3.89% |
| 2026 | 4.15 | 6.31% |
| 2027 | 3.88 | 6.59% |
| 2028 | 3.59 | 7.50% |
| 2029 | 3.31 | 7.75% |
Current Richemont Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Dec 15 2024 |
| BRYAN GARNIER |
Buy
➜
Buy
|
Unchanged | Dec 09 2024 |
| BNP PARIBAS EXANE |
Outperform
➜
Outperform
|
Unchanged | Dec 04 2024 |
| RESEARCH PARTNERS AG |
Hold
➜
Hold
|
Unchanged | Nov 25 2024 |
| HSBC |
Hold
➜
Buy
|
Upgrade | Nov 24 2024 |
| CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED |
Neutral
➜
Neutral
|
Unchanged | Nov 21 2024 |
| TD COWEN |
Hold
➜
Hold
|
Unchanged | Nov 19 2024 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Dec 15 2024 |
|
Unchanged
BRYAN GARNIER:
Buy
➜
Buy
|
Dec 09 2024 |
|
Unchanged
BNP PARIBAS EXANE:
Outperform
➜
Outperform
|
Dec 04 2024 |
|
Unchanged
RESEARCH PARTNERS AG:
Hold
➜
Hold
|
Nov 25 2024 |
|
Upgrade
HSBC:
Hold
➜
Buy
|
Nov 24 2024 |
|
Unchanged
CHINA INTERNATIONAL CAPITAL CORPORATION LIMITED:
Neutral
➜
Neutral
|
Nov 21 2024 |
|
Unchanged
TD COWEN:
Hold
➜
Hold
|
Nov 19 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
